chapter
review
evid
carbohydr
group
may
function
marker
intracellular
transport
sort
membran
secretori
glycoprotein
vertebr
cell
receptormedi
traffick
lysosom
acid
hydrolas
oligosaccharid
chain
contain
mannos
residu
best
understood
pathway
protein
transloc
endoplasm
reticulum
segreg
deliv
ultim
destin
evid
pathway
present
robbin
chapter
volum
well
sever
recent
review
sli
von
figura
hasilik
sahagian
shall
focu
mannos
pathway
chapter
howev
increas
evid
carbyhydr
group
may
also
involv
intracellular
transport
andor
sort
specif
plasma
membran
secretori
protein
shall
review
literatur
relev
topic
sever
experiment
approach
given
evid
proteinbound
glycan
chain
may
import
role
regul
intracellular
glycoprotein
traffic
discuss
chapter
exict
recent
approach
use
sitedirect
mutagenesi
code
sequenc
insert
delet
glycosyl
site
recombin
protein
studi
mutant
cell
shown
glycosyl
defect
often
account
signific
fraction
mutant
isol
select
absenc
cell
surfac
receptor
numer
studi
use
tunicamycin
inhibitor
synthesi
glycan
chain
evalu
function
role
oligosaccharid
chain
glycoprotein
traffic
cell
drug
inhibit
specif
step
major
process
pathway
nlink
glycan
chain
recent
becom
avail
drug
use
studi
evalu
potenti
involv
oligosaccharid
intermedi
glycoprotein
traffic
number
carbohydratebind
protein
lectin
isol
vertebr
cell
shall
also
present
suggest
evid
lectin
may
role
regul
glycoprotein
traffic
interpret
result
studi
carbohydratedefici
protein
synthes
cell
owe
either
mutat
drug
treatment
often
difficult
specif
case
unglycosyl
protein
shown
sensit
proteas
less
solubl
abnorm
fold
therefor
order
evalu
proper
context
evid
carbyhydr
group
direct
role
regul
intracellular
traffic
specif
glycoprotein
brief
overview
present
structur
synthesi
proteinlink
glycan
influenc
glycan
chain
protein
solubl
structur
stabil
proteolyt
degrad
secretori
protein
synthes
ribosom
attach
rough
endoplasm
reticulum
rer
follow
vectori
discharg
lumen
rer
transport
vesicl
rer
golgi
apparatu
final
secretori
vesicl
cell
surfac
palad
tartakoff
farquhar
palad
farquhar
simpl
model
intracellular
transport
secretori
protein
follow
lumin
volum
rer
continu
packag
transport
vesicl
shipment
first
golgi
cell
surfac
sinc
plasma
membran
protein
also
synthes
rer
would
parallel
flow
secretori
plasma
membran
protein
vesicl
cell
surfac
nonspecif
passiveflow
model
protein
transport
predict
sinc
secretori
protein
follow
pathway
kinet
secret
protein
singl
cell
ident
likewis
model
predict
kinet
transport
cell
surfac
plasma
membran
protein
ident
although
passiveflow
model
may
explain
intracellular
transport
protein
cohen
et
al
cohen
phillip
increas
evid
transport
secretori
membran
protein
highli
regul
structur
determin
protein
function
marker
intracellular
transport
strou
lodish
first
report
cell
differ
secretori
protein
secret
markedli
differ
rate
found
use
cultur
rat
hepatoma
cell
newli
synthes
albumin
appear
medium
roughli
twice
fast
transferrin
result
consist
previou
vivo
studi
found
albumin
secret
faster
liver
transferrin
morgan
peter
schreiber
et
al
asynchron
export
secretori
protein
demonstr
human
mous
hepatoma
cell
line
ledford
davi
cultur
rat
hepatocyt
fri
et
al
exocrin
pancrea
scheel
tartakoff
export
nine
secretori
protein
human
hepatoma
cell
tissu
cultur
fell
three
discret
kinet
class
rapidli
secret
class
intracellular
retent
halftim
min
albumin
fibronectin
afetoprotein
r
antitrypsin
intermedi
secret
class
halftim
min
ceruloplasmin
cmacroglobulin
plasminogen
slowli
secret
class
halftim
min
fibrinogen
transferrin
multipl
secretori
rate
singl
cell
suggest
either
multipl
secretori
pathway
secretori
protein
follow
one
common
pathway
cell
differ
rate
mechan
howev
impli
transport
secretori
protein
select
rather
passiveflow
process
specif
receptor
carrier
regul
intracellular
transport
secretori
protein
similar
result
also
report
kinet
intracellular
transport
newli
synthes
membran
protein
fit
kabat
analyz
synthesi
intracellular
transport
two
plasma
membran
glycoprotein
encod
murin
leukemia
viru
found
although
one
viral
membran
protein
transfer
quantit
plasma
membran
virusinfect
cell
within
min
methionin
incorpor
glycoprotein
still
accumul
plasma
membran
min
william
et
al
report
rate
transport
two
close
relat
membran
glycoprotein
class
histocompat
antigen
cell
surfac
remark
differ
ie
hr
versu
hr
found
subcellular
fraction
slowli
transport
protein
accumul
endoplasm
reticulum
er
result
suggest
intracellular
transport
membran
protein
also
select
rather
passiveflow
process
lodish
associ
report
differ
rate
serum
protein
secret
hepatoma
cell
due
variabl
rate
transport
rer
golgi
retent
rer
primarili
respons
overal
rate
secret
postul
one
receptor
protein
rer
membran
regul
select
transport
secretori
protein
transport
vesicl
en
rout
golgi
strou
lodish
lodish
et
al
fit
kabat
reach
similar
conclus
studi
two
viral
glycoprotein
matur
rer
cell
surfac
differ
rate
investig
primari
assay
use
measur
rate
protein
transport
rer
golgi
depend
measur
time
requir
nlink
glycan
chain
becom
resist
digest
endowvacetylglucosaminidas
h
endo
h
acquisit
endo
h
resist
howev
monitor
entri
secretori
glycoprotein
golgi
sinc
oligosaccharid
becom
endo
h
resist
process
amannosidas
ii
event
believ
occur
medial
golgi
compart
therefor
glycoprotein
may
resid
ei
medial
golgi
compart
unknown
period
becom
resist
endo
h
digest
k
employ
three
experiment
approach
ie
cellular
fraction
acquisit
resist
glycan
chain
endo
h
digest
bind
glycoprotein
immobil
plant
lectin
measur
rate
glycoprotein
transport
within
rer
golgi
hepatoma
cell
found
variabl
export
rate
glycoprotein
hepatoma
cell
reflect
heterogen
rate
glycoprotein
transport
within
rer
golgi
transport
receptor
vari
affin
recogn
specif
marker
differ
membran
protein
possibl
isol
mutant
defect
cell
surfac
express
specif
membran
protein
other
sever
mutant
describ
exampl
studi
antigen
synthesi
mutant
mous
lymphoma
cell
establish
specif
oligosaccharid
structur
essenti
matur
antigen
select
group
glycoprotein
cell
surfac
trowbridg
et
al
chapman
et
al
fit
kabat
immunoselect
infect
cell
mutant
defect
surfac
express
either
one
plasma
membran
glycoprotein
encod
murin
leukemia
viru
addit
treatment
cell
drug
inhibit
either
synthesi
normal
process
nlink
glycan
chain
shown
inhibit
appear
cell
surfac
specif
membran
protein
other
see
section
vii
viii
two
type
secretori
rout
identifi
cell
ie
regul
constitut
pathway
tartakoff
vassal
kelli
first
occur
mani
exocrin
endocrin
cell
newli
synthes
secretori
protein
concentr
store
intracellular
granul
await
specif
signal
secret
second
occur
cell
type
includ
fibroblast
muscl
cell
hepatocyt
appar
continu
nonconcentr
exocytosi
secretori
product
sort
secretori
protein
differ
vesicl
demonstr
pituitari
tumor
cell
line
regul
constitut
pathway
gumbin
kelli
moor
et
al
howev
present
unknown
similar
sort
mechan
also
function
cell
like
hepatocyt
lack
regul
pathway
albumin
transferrin
local
intracellular
vesicl
hepatoma
cell
suggest
common
pathway
yokota
fahimi
howev
found
albumin
lipoprotein
separ
packag
er
ei
golgi
intermix
vacuol
tran
golgi
consist
multipl
intracellular
transport
pathway
hepatocyt
carbohydr
chain
glycoprotein
may
classifi
accord
type
linkag
polypeptid
backbon
nglycosid
chain
attach
amid
group
asparagin
wherea
oglycosid
chain
link
hydroxyl
group
amino
acid
residu
serin
threonin
hydroxylysin
recent
review
see
montreuil
montreuil
montreuil
kornfeld
kornfeld
kobata
nglycosid
chain
divid
two
major
class
complextyp
chain
contain
nacetylglucosamin
glcnac
mannos
man
galactos
gal
fucos
fuc
sialic
acid
sa
highmannosetyp
chain
contain
residu
variabl
amount
mannos
olink
chain
commonli
contain
tvacetylgalactosamin
galactos
fucos
sialic
acid
number
differ
oligosaccharid
speci
identifi
vertebr
glycoprotein
larg
number
hundr
synthesi
divers
array
structur
requir
consider
invest
cell
total
biosynthet
capac
least
sialyltransferas
fucosyltransferas
galactosyltransferas
nacetylglucosaminyltransferas
requir
account
biosynthesi
linkag
commonli
observ
mammalian
glycoprotein
beyer
hill
larg
divers
oligosaccharid
speci
found
vertebr
glycoprotein
suggest
proteinlink
glycan
import
role
physiolog
process
requir
larg
inform
content
although
individu
cell
synthes
mani
differ
proteinlink
glycan
chain
process
quit
specif
control
oligosaccharid
chain
individu
glycosyl
site
glycoprotein
one
small
number
close
relat
structur
swiedler
et
al
swiedler
et
al
impli
mani
glycoprotein
specif
structur
oligosaccharid
chain
import
normal
vivo
function
glycoprotein
major
pathway
biosynthesi
complex
highmannos
nlink
glycan
proce
via
common
highmannos
lipidlink
intermedi
structur
glc
man
fig
assembl
dolichollink
highmannos
oligosaccharid
take
place
seri
reaction
refer
lipid
pathway
review
see
snider
krag
kornfeld
kornfeld
first
step
pathway
transfer
udpglcnac
dolichol
phosphat
dolp
form
dolppglcnac
one
glcnac
nine
man
three
glc
residu
ad
mean
correspond
sugar
nucleotid
glycolipid
intermedi
dolpman
dolpglc
result
format
lipidlink
highmannos
oligosaccharid
glc
man
glcnac
assembl
glc
man
oligosaccharid
transfer
en
bloc
nascent
polypeptid
chain
transport
across
insert
rer
membran
glycan
transfer
carri
oligosaccharid
transferas
recogn
acceptor
amino
acid
asparagin
asn
tripeptid
sequenc
asnxser
thr
x
prolin
glc
man
glcnac
oligosaccharid
precursor
highmannos
complextyp
oligosaccharid
order
correspond
convers
take
place
number
trim
reaction
requir
ii
remov
sequenti
outermost
glucos
two
innermost
glucos
residu
amannosidas
activ
remov
four
mannos
residu
addit
glcnac
man
glcnac
oligosaccarid
mannos
residu
creat
core
man
glcnac
oligosaccharid
intermedi
recent
known
oligosaccharidetrim
reaction
involv
remov
one
sugar
residu
propos
sequenc
process
peptidebound
nlink
glycan
site
inhibit
follow
drug
indic
line
arrow
dnm
mdnm
nmethylldeoxynorjirimycin
cs
castanospermin
bc
bromoconduritol
dmm
sw
swainsonin
reaction
catalyz
follow
enzym
oligosaccharyltransferas
rer
rer
aglucosidas
ii
rer
golgi
ib
golgi
nacetylglucosaminyltransferas
golgi
amannosidas
ii
nacetylglucosaminyltransferas
ii
iv
fucosyltransferas
galactosyltransferas
sialyltransferas
symbol
nacetylglucosamin
mannos
glucos
fucos
galactos
sialic
acid
adapt
kornfeld
et
al
singl
step
howev
luba
spiro
report
rat
liver
membran
contain
novel
enzym
capac
trim
glciman
glcnac
man
glcnac
remov
disaccharid
oligosaccharid
trim
sugar
nacetylglucosamin
galactos
sialic
acid
fucos
may
ad
sequenti
correspond
glycosyltransferas
form
glycan
complex
type
first
process
reaction
remov
two
three
glucos
residu
perhap
also
remov
singl
mannos
residu
glc
man
glcnac
oligosaccharid
occur
rer
howev
bulk
oligosaccharid
process
reaction
occur
golgi
recent
studi
shown
process
enzym
local
specif
subcompart
golgi
stack
recent
review
see
farquhar
hirschberg
snider
use
immunocytochem
techniqu
thin
section
hela
cell
roth
berger
show
galactosyltransferas
local
two
three
tran
cisterna
golgi
stack
local
aacetylglucosaminyltransferas
medial
golgi
cisterna
current
thought
sequenti
process
reaction
nlink
oligosaccharid
occur
stepwis
transfer
glycoprotein
site
initi
assembl
rer
subcompart
golgi
apparatu
final
destin
cell
surfac
extracellular
space
intracellular
organel
therefor
intermedi
nlink
oligosaccharid
process
pathway
appropri
marker
follow
stepwis
transport
glycoprotein
subcellular
compart
rotundo
gabel
bergmann
unusu
featur
biosynthet
pathway
nlink
oligosaccharid
specif
trim
nine
sugar
residu
precursor
oligosaccharid
transfer
addit
glcnac
galactos
sialic
acid
fucos
residu
form
complex
structur
appear
wast
unless
oligosaccharid
intermedi
import
role
within
cell
recent
studi
use
specif
inhibitor
ii
demonstr
trim
three
glucos
residu
er
requir
effici
transport
secretori
plasma
membran
lysosom
enzym
er
golgi
apparatu
gross
et
al
lodish
kong
lemanski
et
al
repp
et
al
parent
et
al
although
glc
man
glcnac
appear
major
oligosaccharid
transfer
lipid
protein
also
evid
altern
pathway
nlink
glycosyl
complet
discuss
see
krag
import
point
nlink
oligosaccharid
chain
process
along
ident
pathway
er
ei
golgi
unlik
earli
oligosaccharid
intermedi
pathway
would
role
rout
glycoprotein
differ
cellular
locat
howev
normal
cultur
condit
chines
hamster
ovari
cho
cell
synthes
low
level
lipidlink
glc
man
addit
predomin
glc
man
speci
rais
possibl
cell
second
glycosyl
pathway
two
mutant
cell
line
class
e
lymphoma
cell
chapman
et
al
cho
cell
stoll
et
al
known
transfer
glc
man
glcnac
protein
subsequ
process
speci
form
complextyp
oligosaccharid
similar
result
obtain
glucosedepriv
cho
cell
rearick
et
al
cell
treat
inhibitor
oxid
phosphoryl
datema
schwarz
yamashita
et
al
present
evid
sugar
chain
ovomucoid
ovalbumin
synthes
use
differ
lipid
intermedi
suggest
lipidlink
man
glcnac
may
oligosaccharid
donor
ovomucoid
wherea
lipidlink
glc
man
glcnac
donor
ovalbumin
sinc
ovalbumin
ovomucoid
synthes
chicken
oviduct
result
impli
glycan
chain
differ
protein
cell
may
process
differ
pathway
recent
gener
accept
presenc
glucos
oligosaccharid
precursor
requir
transfer
mammalian
cell
howev
romero
herscov
demonstr
transfer
nonglucosyl
oligosaccharid
man
glcnac
dolichol
pyrophosph
protein
cell
mammalian
cell
line
parodi
et
al
shown
glucosefre
oligosaccharid
transfer
nglycosyl
protein
protozoa
trypanosoma
cruzi
mechan
also
describ
yeast
mutant
block
biosynthesi
dolichol
pyrophosph
oligosaccharid
huffak
robbin
rung
et
al
enzym
found
tritontr
rat
liver
golgi
membran
trim
glciman
man
glcnac
releas
luba
spiro
remov
glucosylmannos
disaccharid
endoadmannosidas
provid
process
rout
altern
sequenti
action
amannosidas
author
suggest
remov
dissaccharid
nlink
glycan
golgi
could
serv
signal
direct
intracellular
movement
sort
certain
protein
trim
four
mannos
residu
man
glcnac
oligosaccharid
accomplish
two
golgi
enzym
l
ib
tulsiani
et
al
two
enzym
present
compar
activ
membran
enrich
golgi
enzym
quit
similar
substrat
specif
respons
inhibitor
howev
clearli
distinguish
basi
behavior
cellulos
phosphat
chromatographi
thermol
activ
toward
man
glcnac
nitrophenylmannosid
tulsiani
et
al
point
exist
two
distinct
golgi
enzym
trim
mannos
residu
oligosaccharid
chain
rais
possibl
differ
process
rout
occur
within
golgi
apparatu
lead
differ
class
glycoprotein
andor
differ
subsequ
rout
interestingli
mannos
trim
oligosaccharid
destin
becom
highmannosetyp
structur
matur
chain
immunoglobulin
igm
found
much
rapid
mannos
trim
oligosaccharid
destin
becom
complextyp
structur
brown
hickman
addit
evid
multipl
pathway
find
glucos
directli
transfer
udpglucos
nlink
glycan
chain
thyroid
liver
tissu
sampl
reaction
occur
liver
rer
membran
fraction
ronin
caseti
parodi
et
al
parodi
et
al
b
parodi
et
al
b
suggest
transient
glucosyl
nlink
carbohydr
might
respons
rout
glycoprotein
specif
cellular
locat
factor
specifi
structur
glycan
specif
site
protein
unlik
case
templatedirect
synthesi
protein
nucleic
acid
nlink
glycan
chain
synthes
sequenti
activ
specif
glycosyl
transferas
glycosidas
sinc
singl
cell
synthes
divers
array
glycan
inform
determin
oligosaccharid
structur
individu
glycosyl
site
glycoprotein
must
specifi
larg
part
primari
structur
protein
impli
even
oligosaccharid
chain
function
transport
marker
glycoprotein
traffic
cell
perhap
interact
specif
carbohydratebind
receptor
carrier
protein
inform
specifi
transport
marker
must
ultim
resid
protein
gene
encod
protein
argument
support
recent
studi
specif
recognit
lysosom
enzym
udpivacetylglucosaminelysosomalenzym
nacetylglucosaminephosphotransferas
glcnacptransferas
enzym
respons
transfer
select
man
residu
lysosom
enzym
reaction
first
twostep
synthesi
recognit
marker
segreg
acid
hydrolas
lysosom
kornfeld
kornfeld
von
figura
hasilik
shown
glcnacptransferas
select
phosphoryl
lysosom
enzym
abl
recogn
nonlysosom
glycoprotein
high
concentr
reitman
kornfeld
b
wahe
et
al
kornfeld
cowork
found
determin
allow
select
recognit
lysosom
enzym
enzym
protein
rather
oligosaccharid
portion
lysosom
enzym
molecul
deglycosyl
enzym
ie
endo
h
treat
prove
specif
inhibitor
phosphoryl
intact
enzym
lang
et
al
moreov
intact
protein
may
requir
even
larg
proteolyt
fragment
retain
abil
recogn
evid
primari
structur
protein
import
role
specifi
process
nlink
chain
complex
highmannos
form
obtain
analyz
type
oligosaccharid
present
close
relat
viral
glycoprotein
isol
host
cell
sinc
viru
util
process
enzym
host
cell
differ
oligosaccharid
structur
reflect
differ
viral
glycoprotein
differ
process
nlink
glycan
chain
viral
glycoprotein
complex
highmannos
form
observ
differ
strain
either
influenza
viru
vesicular
stomat
viru
vsv
grown
host
cell
nakamura
compan
schwarz
klenk
hunt
et
al
close
relat
murin
leukemia
virus
grown
number
host
variou
growth
condit
rosner
et
al
evid
primari
structur
protein
also
influenc
finer
aspect
nlink
glycan
structur
come
work
swiedler
et
al
use
murin
b
cell
lymphoma
cell
line
simultan
synthes
two
class
major
histocompat
antigen
within
class
share
high
degre
amino
acid
sequenc
homolog
possess
nlink
glycosyl
site
invari
posit
found
specif
pattern
sialyl
branch
individu
glycosyl
site
structur
relat
glycoprotein
uniqu
suggest
subtl
differ
peptid
structur
import
influenc
branch
sialyl
nlink
oligosaccharid
shear
robbin
studi
express
glycosyl
chicken
ovalbumin
gene
heterolog
cell
mous
l
cell
matur
chicken
ovalbumin
heterogen
respect
oligosaccharid
chain
approxim
equal
amount
highmannos
hybrid
form
hybrid
chain
three
alink
mannos
residu
addit
termin
glcnac
gal
sialic
acid
residu
ovalbumin
repres
rare
class
glycoprotein
contain
larg
amount
hybrid
chain
interestingli
chicken
ovalbumin
secret
mous
l
cell
process
predominantli
hybrid
structur
suggest
polypeptid
chain
ovalbumin
respons
process
substanti
fraction
oligosaccharid
side
chain
hybrid
structur
although
much
work
focus
glycosyl
secretori
cell
surfac
glycoprotein
compar
littl
known
glycosyl
resid
glycoconjug
subcellular
organel
recent
two
group
describ
novel
proteinsaccharid
linkag
olink
glcnac
torr
hart
schindler
et
al
structur
kda
protein
major
compon
nuclear
pore
complex
davi
blobel
schindler
et
al
schindler
hogan
postul
glycosyl
olink
glcnac
monosaccharid
residu
could
serv
direct
transport
protein
nucleu
manner
analog
target
lysosom
enzym
lysosom
via
attach
mannos
residu
howev
find
olink
glcnac
moieti
also
found
subcellular
compart
may
argu
model
holt
hart
presenc
glycan
chain
great
effect
solubl
properti
glycoprotein
tarentino
et
al
mani
protein
function
aqueou
environ
environ
tend
orient
hydrophob
residu
interior
protein
hydrophil
residu
exterior
oligosaccharid
chain
substanti
contribut
net
hydrophil
exterior
surfac
protein
influenc
protein
solubl
hydrophil
sugar
residu
net
ionic
charg
physiolog
ph
sialic
acid
carri
one
net
neg
charg
therefor
presenc
nlink
olink
oligosaccharid
chain
contain
sialic
acid
substanti
affect
net
charg
glycoprotein
schauer
effect
coval
attach
carbohydr
solubl
number
protein
examin
lawson
et
al
use
polyethylen
glycol
precipit
found
increas
decreas
protein
solubl
depend
state
glycosyl
type
protein
temperatur
exampl
ribonucleas
nonglycosyl
less
solubl
ribonucleas
b
one
nglycan
chain
contain
man
glcnac
temperatur
higher
temperatur
b
form
slightli
less
solubl
protein
conform
may
alter
presenc
oligosaccharid
chain
howev
rel
import
carbohydr
chain
conform
fold
glycoprotein
unclear
enzymat
remov
carbohydr
glycoprotein
enzym
usual
littl
effect
catalyt
effici
enzym
demonstr
numer
enzym
includ
rnase
b
dnase
invertas
carboxypeptidas
mung
bean
nucleas
tarentino
et
al
trimbl
maley
sinc
nlink
glycosyl
glycoprotein
earli
event
often
occur
nascent
chain
rer
bergman
kuehl
possibl
nlink
oligosaccharid
side
chain
may
influenc
proper
fold
nascent
protein
would
explain
remov
oligosaccharid
unit
matur
protein
alreadi
achiev
correct
conform
might
deleteri
effect
recent
year
howev
number
eukaryot
glycoprotein
produc
escherichia
coli
use
recombin
dna
technolog
mani
protein
fulli
activ
despit
absenc
glycosyl
suggest
glycan
chain
requir
proper
fold
protein
exampl
includ
fibroblast
interferon
derynck
et
al
immun
interferon
grey
et
al
grey
goeddel
plasminogen
activ
pennica
et
al
r
antitrypsin
courtney
et
al
urokinas
gunnzler
et
al
interleukin
svederski
et
al
influenc
carbohydr
conform
refold
pancreat
ribonucleas
extens
studi
use
variou
spectral
properti
circular
dichroism
optic
rotatori
dispers
uv
differ
spectroscopi
puett
conclud
secondari
tertiari
structur
glycosyl
nonglycosyl
bovin
rnase
ident
known
ribonucleas
procin
enzym
highest
report
content
carbohydr
around
studi
compar
glycosyl
nonglycosyl
porcin
rnase
wang
hir
found
carbohydr
without
influenc
ratelimit
step
refold
protein
denatur
state
overal
configur
stabil
molecul
influenc
environ
around
two
tyrosin
side
chain
effect
stabil
surfac
structur
effect
observ
rel
small
howev
two
recent
studi
also
report
mechan
fold
pancreat
ribonucleas
independ
coval
link
carbohydr
kreb
et
al
grafl
et
al
appar
inform
fold
ribonucleas
perhap
glycoprotein
contain
exclus
protein
moieti
ie
amino
acid
sequenc
chu
et
al
found
presenc
carbohydr
yeast
invertas
stabil
enzym
denatur
mild
acid
heat
repeat
cycl
freez
thaw
remov
oligosaccharid
carboxypeptidas
digest
endo
h
doubl
rate
inactiv
treatment
sodium
dodecyl
sulfat
compar
glycosyl
enzym
chu
maley
assum
form
bound
amount
deterg
result
suggest
carbohydr
may
help
maintain
activ
conform
enzym
effect
deplet
envelop
glycoprotein
carbohydr
extens
studi
g
protein
vesicular
stomat
viru
vsv
gibson
et
al
gibson
et
al
gibson
et
al
leavitt
et
al
nonglycosyl
g
protein
vsv
san
juan
transport
cell
surfac
aggreg
er
viru
grown
cell
treat
tunicamycin
tm
either
normal
temperatur
lower
temperatur
nonglycosyl
g
protein
anoth
vsv
strain
orsay
howev
partial
transport
cell
surfac
lower
temperatur
similar
strain
differ
found
use
vitro
assay
design
measur
solubl
nonion
deterg
aggreg
nonglycosyl
g
protein
aggreg
dramat
g
protein
san
juan
also
evid
g
protein
orsay
higher
temperatur
gibson
et
al
strain
differ
also
note
assay
aggreg
g
protein
isol
vsvinfect
mutant
cell
line
truncat
core
oligosaccharid
transfer
polypeptid
chain
gibson
et
ai
g
protein
san
juan
orsay
viru
strain
close
relat
contain
amino
acid
differ
gallion
rose
amino
acid
differ
must
respons
variat
carbohydr
requir
solubl
result
studi
use
two
vsv
strain
interpret
indic
carbohydr
signific
influenc
fold
conform
g
protein
gibson
et
al
point
howev
alter
fold
conform
g
protein
directli
demonstr
studi
rather
influenc
carbohydr
aggreg
solubl
properti
g
protein
two
vsv
strain
demonstr
sinc
carbohydr
chain
per
se
larg
effect
temperaturedepend
solubl
properti
glycoprotein
clear
result
studi
carbohydr
significantli
alter
conform
g
protein
perhap
one
reason
glycan
chain
appear
major
effect
conform
mani
glycoprotein
glycan
chain
locat
near
turn
turn
loop
structur
protein
beeley
appli
method
predict
peptid
chain
conform
amino
acid
sequenc
adjac
carbohydr
attach
site
glycoprotein
contain
nlink
oligosaccharid
chain
glycosyl
residu
examin
occur
sequenc
favor
turn
loop
structur
twentytwo
glycosyl
asparagin
residu
occur
tetrapeptid
predict
conform
similar
conclus
drawn
anoth
studi
oglycosid
linkag
nglycosid
linkag
aubert
et
al
oglycosid
linkag
serin
threonin
residu
involv
linkag
predict
turn
nineteen
nglycosid
linkag
occur
sequenc
favor
turn
nglycosid
linkag
locat
turn
situat
random
region
near
turn
probabl
expos
solvent
near
carboxytermin
end
numer
studi
suggest
presenc
oligosaccharid
chain
protein
may
decreas
suscept
proteas
recent
review
see
olden
et
al
studi
includ
comparison
loss
activ
treatment
proteas
vitro
comparison
turnov
rate
vivo
treatment
cell
inhibitor
glycosyl
reason
increas
suscept
nonglycosyl
protein
probabl
vari
protein
one
reason
howev
may
decreas
protect
proteas
bend
turn
polypeptid
backbon
believ
occur
glycosyl
site
glycoprotein
baus
case
rapid
degrad
nonglycosyl
secretori
protein
tmtreat
cell
may
due
improp
compartment
lysosom
proteas
secretori
protein
rather
inher
sensit
nonglycosyl
protein
proteolyt
attack
tm
treatment
cell
interfer
transport
acid
hydrolas
lysosom
found
chicken
embryo
fibroblast
treat
tm
secret
lysosom
cathepsin
blike
activ
exampl
protein
known
increas
suscept
proteas
nonglycosyl
form
includ
hemagglutinin
precursor
influenza
viru
schwarz
et
al
fibronectin
chick
embryo
fibroblast
bernard
et
al
hyne
yamada
adrenocorticotropinendorphin
precursor
toad
pituitari
loh
gainer
alkalin
phosphatas
murin
cell
fireston
heath
carboxypeptidas
yeast
cell
chu
maley
laboratori
john
rose
recent
develop
novel
experiment
approach
studi
role
carbohydr
glycoprotein
traffic
use
sitedirect
mutagenesi
code
sequenc
either
insert
delet
glycosyl
site
clone
protein
use
techniqu
macham
et
al
investig
role
glycosyl
intracellular
transport
cell
surfac
express
vsv
g
protein
cell
express
g
protein
clone
cdna
individu
contribut
two
nlink
oligosaccharid
chain
g
protein
cell
surfac
express
assess
elimin
one
glycosyl
site
clone
protein
interestingli
found
one
oligosaccharid
chain
either
posit
suffici
cell
surfac
express
g
protein
transfect
cell
appar
rate
intracellular
transport
protein
similar
rate
observ
wildtyp
protein
howev
nonglycosyl
g
protein
synthes
glycosyl
site
elimin
reach
cell
surfac
protein
appear
reach
golgilik
region
determin
immunofluoresc
microscopi
subject
increas
intracellular
proteolyt
degrad
result
suggest
carbohydr
direct
signal
intracellular
transport
g
protein
golgi
cell
surfac
altern
model
carbohydr
requir
maintain
polypeptid
conform
essenti
intracellular
transport
model
less
appeal
howev
glycosyl
either
site
promot
effici
transport
g
protein
seem
unlik
glycosyl
two
differ
posit
molecul
would
induc
conform
chang
addit
macham
rose
introduc
glycosyl
site
sever
new
posit
g
protein
lack
two
normal
site
initi
result
show
least
one
new
glycosyl
site
promot
transport
g
protein
cell
surfac
addit
evid
carbohydr
signal
intracellular
transport
come
studi
hybrid
membran
protein
guan
rose
construct
hybrid
gene
encod
membraneanchor
form
rat
growth
hormon
protein
anchor
cellular
membran
carboxytermin
extens
hormon
compos
transmembran
cytoplasm
domain
vsv
g
protein
protein
transport
effici
golgi
cell
surfac
order
determin
nlink
carbohydr
promot
surfac
express
hybrid
protein
guan
et
al
gener
mutant
protein
use
vitro
mutagenesi
singl
amino
acid
two
site
anchor
growth
hormon
chang
gener
consensu
sequenc
requir
addit
nlink
ohgosaccharid
mutant
protein
protein
glycosyl
site
glycosyl
transport
cell
surfac
kalderon
et
al
suggest
one
criterion
transport
signal
abl
function
multipl
site
polypeptid
chain
therefor
find
glycosyl
multipl
site
g
protein
well
growth
hormonehybrid
membran
protein
promot
effici
transport
cell
surfac
strong
evid
carbohydr
function
transport
signal
protein
frequent
found
mutant
defect
surfac
appear
membran
protein
defect
carbohydr
process
stanley
stanley
tartakoff
perhap
extens
studi
concern
surfac
express
surfac
antigen
mous
lymphoma
cell
trowbridg
et
al
b
trowbridg
hyman
glycoprotein
carbohydr
weight
barclay
molecul
rat
brain
contain
three
nlink
oligosaccharid
campbel
found
neuron
lymphocyt
mani
anim
speci
abund
surfac
protein
mous
cell
mutant
mous
lymphoma
cell
bore
less
much
surfac
wildtyp
cell
select
sever
clone
identifi
continu
synthes
appar
defect
intracellular
transport
mutat
prove
recess
five
complement
class
mutant
cell
character
somat
genet
analysi
defect
oligosaccharid
unit
glycoprotein
demonstr
four
five
class
mutant
specif
defect
mutant
class
remain
unknown
howev
case
mutant
belong
complement
group
e
analysi
taken
much
class
e
mutat
shown
due
mutat
gene
act
transfer
mannos
gdpmannos
dolichol
phosphat
chapman
et
al
consequ
class
e
mutant
cell
unabl
synthes
normal
lipidlink
glcnac
oligosaccharid
instead
synthes
smaller
glcnac
moieti
transfer
nascent
polypeptid
consequ
cell
surfac
glycoprotein
class
e
mutant
cell
show
pleiotrop
alter
mannosecontain
nlink
oligosaccharid
interestingli
lipidlink
glc
man
also
identifi
minor
speci
present
normal
cho
cell
may
oligosaccharid
donor
lipid
specif
protein
normal
cell
yamashita
et
al
mani
cell
surfac
glycoprotein
express
normal
class
e
mutant
cell
howev
addit
glycoprotein
molecul
bear
determin
express
cell
surfac
class
e
mutant
cell
horton
hyman
probabl
due
select
defect
mutant
cell
viabl
immunocytochem
studi
show
wildtyp
cell
glycoprotein
predominantli
local
cell
surfac
minim
amount
distribut
cytoplasm
class
e
mutant
cell
glycoprotein
express
cell
surfac
detect
er
golgi
region
lysosom
bourguignon
et
al
clear
lesion
normal
oligosaccharid
process
characterist
class
e
mutant
cell
prevent
transport
glycoprotein
cell
surfac
howev
specif
chang
oligosaccharid
structur
necessari
block
transport
glycoprotein
lectinresist
mutant
specif
defect
glycosyl
select
mous
lymphoma
cell
trowbridg
et
al
glycosyl
defect
confer
resist
cytotox
effect
concanavalin
block
express
glycoprotein
cell
surfac
howev
glycosyl
defect
lectinresist
mutant
effect
transport
solubl
properti
deterg
molecul
isol
cell
suggest
block
transport
due
aggreg
precipit
abnorm
glycosyl
molecul
within
cell
trowbridg
et
al
appar
transfer
normal
oligosaccharid
precursor
protein
requir
transport
glycoprotein
select
group
glycoprotein
cell
surfac
mous
lymphoma
cell
known
howev
alter
oligosaccharid
process
primari
defect
prevent
transport
class
e
mutant
altern
activ
anoth
protein
regul
intracellular
transport
may
affect
pleiotrop
mutant
cho
mutant
isol
decreas
level
receptor
activ
shown
gener
defect
synthesi
highmannos
nlink
carbohydr
chain
defect
result
inabl
cell
synthes
mannosylphosphoryldolichol
similar
class
e
mutat
stoll
et
al
lysosom
enzym
cho
mutant
synthes
truncat
oligosaccharidedolichol
precursor
appear
acquir
recognit
marker
stoll
et
al
gabel
kornfeld
howev
compartment
correctli
mutant
cell
alter
receptor
larg
number
mutant
cho
cell
express
activ
cell
surfac
low
densiti
lipoprotein
ldl
receptor
isol
shown
fall
four
complement
group
ldlaldld
somat
genet
analysi
recent
review
see
krieger
et
al
mutant
three
complement
group
ldlbldld
defect
process
nlink
olink
lipidlink
carbohydr
chain
kingsley
et
al
ldl
receptor
synthes
cultur
human
cell
contain
one
nlink
glycan
chain
six
nine
olink
chain
glycosyl
defect
dramat
affect
ldl
receptor
function
specif
sinc
differ
type
previous
isol
cho
glycosyl
mutant
nearli
normal
level
ldl
receptor
function
ldlb
ldld
mutant
signific
level
cell
surfac
receptor
activ
therefor
express
specif
surfac
protein
affect
glycosyl
defect
leichter
krieger
enhanc
degrad
ldl
receptor
ldlb
ldlc
ldld
mutant
larg
account
ldl
receptordefici
phenotyp
although
defect
transport
mutant
receptor
cell
surfac
may
also
involv
biochem
lesion
caus
glycosyl
defect
ldl
receptordefici
phenotyp
ldlb
ldlc
mutant
unknown
structur
chang
idld
cell
howev
account
gener
defect
addit
gal
galnac
residu
glycoconjug
caus
sever
defici
udpgaludpgalnac
activ
kingsley
et
al
without
enzym
idld
cell
unabl
synthes
normal
amount
udpgal
udpgalnac
correspond
glc
precursor
addit
gal
galnac
cultur
medium
allow
idld
mutant
synthes
udpsugar
via
salvag
pathway
fulli
correct
structur
defect
cell
gal
alon
fulli
correct
nlink
olink
process
defect
induc
ldl
receptor
activ
contrast
galnac
alon
partial
correct
olink
nlink
process
defect
substanti
increas
ldl
receptor
activ
thu
appear
defect
olink
process
may
primari
caus
ldl
receptordefici
phenotyp
idld
mutant
seventi
olink
chain
ldl
receptor
cluster
singl
serinethreoninerich
domain
protein
domain
delet
without
affect
either
function
stabil
ldl
receptor
olink
chain
elsewher
ldl
receptor
may
particularli
import
ldl
receptor
function
altern
addit
galnac
cultur
medium
idld
mutant
may
alter
cell
compon
normal
interact
ldl
receptor
protein
exampl
mutant
cell
discuss
mutat
alter
abil
cell
accomplish
normal
glycosyl
glycoprotein
alter
machineri
glycoprotein
transport
often
result
pleiotrop
defect
express
mani
glycoprotein
mutant
cell
close
associ
glycosyl
defect
alter
express
antigen
receptor
ldl
receptor
emphas
import
carbohydr
chain
express
function
cell
surfac
glycoprotein
theori
mutat
could
also
alter
primari
structur
protein
undergo
transport
therebi
prevent
normal
attach
process
carbohydr
transport
marker
possibl
exampl
categori
transport
mutat
may
found
human
diseas
r
antitrypsin
defici
recent
review
see
carrel
et
al
r
antitrypsin
princip
proteas
inhibitor
serum
singl
poli
peptid
glycoprotein
normal
form
serum
three
complex
nlink
oligosaccharid
hodg
et
al
mega
et
al
z
variant
allel
encod
mutant
protein
singl
substitut
glutam
acid
lysin
posit
yoshida
et
al
jeppsson
sinc
homozygot
z
allel
reduct
circul
level
ajantitrypsin
substanti
deposit
accumul
within
rer
hypatocyt
appear
defect
secret
z
variant
z
form
r
antitrypsin
isol
rer
inclus
normal
proteas
inhibitori
activ
essenti
normal
thermal
stabil
thu
z
variant
arantitrypsin
must
nativ
form
reactiv
center
intact
strain
conform
lobermann
et
al
unlik
accumul
rer
due
gross
misfold
polypeptid
interestingli
rer
inclus
recov
liver
zz
homozygot
contain
arantitrypsin
bear
highmannos
nlink
glycan
chain
attach
glucos
residu
hercz
et
al
hercz
harpaz
bathurst
et
al
remov
glucos
oligosaccharid
precursor
glycoprotein
usual
occur
rapidli
transfer
protein
hubbard
robbin
atkinson
lee
treatment
rat
hepatocyt
human
hepatoma
cell
deoxynorjirimycin
inhibitor
process
er
glucosidas
shown
inhibit
secret
transport
r
antitrypsin
rer
golgi
postul
lodish
kong
oligosaccharid
process
intermedi
may
function
part
tag
rapid
transport
r
antitrypsin
rer
golgi
gross
et
al
lodish
kong
parent
et
al
plausibl
hypothesi
z
form
r
antitrypsin
accumul
liver
zz
homozygot
singl
amino
acid
substitut
primari
sequenc
alter
conform
molecul
therebi
prevent
trim
glucos
residu
nlink
glycan
chain
r
antitrypsin
consequ
rapid
receptormedi
transport
r
antitrypsin
rer
golgi
block
context
interest
class
cellular
transport
mutant
identifi
among
immunoselect
cell
infect
friend
erythroleukemia
viru
viral
glycoprotein
transport
cell
surfac
intracellular
mutant
contain
immatur
form
highmannos
oligosaccharid
contain
glucos
ruta
et
al
one
wide
use
inhibitor
evalu
role
nlink
oligosaccharid
transport
express
secretori
membran
glycoprotein
tunicamycin
tm
nucleosid
analog
isol
streptomyc
lysosuperificu
takatsuki
et
al
antibiot
inhibit
transfer
udpglcnac
dolp
lampen
takatsuki
et
al
sinc
step
first
lipidlink
pathway
tm
treatment
block
nlink
glycosyl
protein
review
see
schwarz
datema
b
elbein
believ
confus
interpret
result
use
drug
sometim
assum
nlink
oligosaccharid
import
role
intracellular
transport
secretori
membran
glycoprotein
tm
treatment
total
block
secret
surfac
express
protein
therefor
appear
cell
surfac
tmtreat
cell
even
greatli
reduc
level
secretori
membran
protein
use
evid
studi
carbohydr
import
role
glycoprotein
transport
cell
surfac
howev
assumpt
mislead
recent
studi
mostli
transport
acid
hydrolas
lysosom
clearli
demonstr
cell
export
protein
nonspecif
pathway
receptormedi
pathway
inop
cell
defect
pathway
either
defici
function
receptor
myerowitz
gonzaleznoriega
et
al
lack
enzym
synthesi
transport
marker
kornfeld
kornfeld
von
figura
hasilik
low
level
activ
acid
hydrolas
lysosom
secret
larg
amount
acid
hydrolas
also
evid
nonspecif
pathway
protein
export
yeast
normal
carboxypeptidas
vacuolar
enzym
yeast
analog
lysosom
enzym
mammal
effici
local
vacuol
plasmiddirect
overproduct
howev
result
secret
larg
fraction
protein
appar
carboxypeptidas
ysort
receptor
satur
steven
et
al
nonspecif
pathway
protein
export
oper
receptormedi
pathway
inop
may
analog
passiv
flow
protein
vesicl
rer
golgi
cell
surfac
therefor
logic
expect
tm
treatment
would
total
prevent
surfac
appear
secretori
membran
glycoprotein
even
carbohydr
import
function
role
normal
transport
protein
tm
treatment
howev
may
substanti
alter
kinet
intracellular
transport
secretori
membran
protein
well
precis
pathway
taken
protein
site
synthesi
rer
cell
surfac
effect
tm
secret
immunoglogulin
extens
studi
differ
class
immunoglobulin
differ
carbohydr
requir
secret
thu
secret
igm
ige
almost
total
inhibit
tm
secret
ig
partial
inhibit
secret
igg
essenti
unaffect
hickman
et
al
hickman
ig
accumul
rer
increas
intracellular
degrad
nonglycosyl
immunoglobulin
could
demonstr
extent
inhibit
immunoglobulin
secret
tm
studi
correl
carbohydr
content
variou
immunoglobulin
class
hickman
kornfeld
suggest
molecul
highli
glycosyl
might
affect
inhibit
glycosyl
howev
sidman
found
secret
igd
heavili
glycosyl
igm
inhibit
tm
survey
publish
studi
use
drug
suggest
correl
extent
glycosyl
secretori
protein
sensit
secret
tm
level
differenti
cell
may
import
determin
sensit
tm
sibley
wagner
found
secret
igm
mous
b
cell
lymphoma
affect
tm
treatment
contrast
profound
inhibit
secret
observ
hickman
kornfeld
plasmacytoma
cell
treat
tm
although
cell
secret
igm
two
model
cell
differ
point
along
b
cell
differenti
pathway
plasmacytoma
cell
synthes
time
much
igm
b
cell
lymphoma
interestingli
ciccimarra
et
al
describ
defect
agammaglobulinemia
igg
secretori
block
associ
failur
glycosyl
igg
heavi
chain
incorpor
h
mannos
h
glucosamin
cellular
protein
normal
singl
cell
tm
inhibit
secret
specif
glycoprotein
export
glycoprotein
unaffect
tm
treatment
human
hepatoma
cell
significantli
delay
secret
macroglobulin
ceruloplasmin
secret
transferrin
fibrinogen
afetoprotein
fibronectin
plasminogen
affect
drug
dramat
effect
tm
treatment
secret
macroglobulin
protein
still
present
cell
fraction
undegrad
form
hr
synthesi
control
cell
newli
synthes
macroglobulin
secret
min
tm
treatment
human
hepatoma
cell
also
markedli
affect
thyroxinebind
globulin
tbg
secret
almost
doubl
time
requir
secret
protein
bartalena
robbin
secret
major
glycoprotein
constitu
mous
egg
extracellular
coat
inhibit
tm
nonglycosyl
accumul
intracellularli
roller
wassarman
howev
tm
inhibit
secret
anoth
mous
egg
glycoprotein
tm
inhibit
secret
proteolyt
process
preproafactor
yeast
juliu
et
al
effect
appear
transport
sinc
intracellular
form
accumul
inhibit
glycosyl
secret
acid
phosphatas
yeast
tm
result
synthesi
nonglycosyl
membraneassoci
form
enzym
mizunaga
noguchi
treatment
human
umbil
vein
endotheli
cell
tm
inhibit
secret
von
willebrand
factor
vwf
wagner
et
al
nonglycosyl
provwf
monom
fail
dimer
process
accumul
rer
appar
effect
tm
degrad
tm
inhibit
vwf
transport
process
specif
human
endotheli
cell
sinc
precursor
subunit
cleav
secret
bovin
cell
presenc
tm
lynch
et
al
tm
inhibit
intracellular
movement
secret
procollagen
human
fibroblast
housley
et
al
secret
procollagen
minim
affect
tm
chick
fibroblast
duksin
bornstein
olden
et
al
tm
markedli
inhibit
secret
surfactantassoci
glycoprotein
lung
epitheli
cell
whitsett
et
al
secret
thyroglobulin
cell
ekholm
eggo
burrow
tm
treatment
significantli
affect
ovalbumin
secret
chick
oviduct
keller
swank
low
densiti
lipoprotein
assembl
secret
hepatocyt
siutamangano
et
al
process
secret
haptoglobin
rat
hepatocyt
hanley
et
al
process
secret
proopiomelanocortin
peptid
mous
pituitari
cell
budarf
herbert
glycosyl
import
structur
function
matur
insulin
receptor
transloc
cell
membran
reed
et
al
ronnett
lane
ronnett
et
al
treatment
cell
tm
rapidli
deplet
cell
surfac
insulinbind
capac
lead
product
kda
polypeptid
precipit
antibodi
insulin
receptor
proteolyt
cleav
yield
subunit
bind
insulin
reach
cell
surfac
ronnett
lane
shown
heavi
isotop
densiti
shift
method
block
glycosyl
tm
caus
intracellular
accumul
inact
nonglycosyl
receptor
subsequ
withdraw
tm
shift
cell
heavi
medium
n
c
hlabel
amino
acid
led
activ
previous
synthes
light
receptor
similar
level
light
receptor
accru
even
protein
synthesi
block
cycloheximid
appar
inact
nonglycosyl
receptor
accumul
tm
treatment
reenter
glycosyl
pathway
remov
inhibitor
sinc
transfer
oligosaccharid
oligosaccharidelipid
donor
protein
occur
er
result
suggest
nlink
oligosaccharid
chain
requir
transport
receptor
precursor
rer
inhibitor
nlink
glycosyl
tm
glucosamin
also
prevent
matur
transloc
cell
surfac
activ
epiderm
growth
factor
egf
receptor
soderquist
carpent
slieker
lane
transferrin
receptor
highmannos
complextyp
oligosaccharid
side
chain
transport
cell
surfac
presenc
tm
level
surfac
receptor
significantli
reduc
compar
untreat
cell
omari
trowbridg
ldl
receptor
express
reduc
cell
surfac
follow
tm
treatment
chatterje
et
al
chatterje
et
al
filipov
von
figura
cell
surfac
acetylcholin
receptor
express
greatli
decreas
muscl
cell
treat
tm
merli
et
al
found
tm
treatment
mous
muscl
cell
line
decreas
amount
function
acetylcholin
receptor
block
assembl
subunit
precursor
matur
function
molecul
suggest
tm
may
prevent
transport
subunit
golgi
assembl
may
occur
prive
barsagi
suggest
enhanc
proteolyt
degrad
nonglycosyl
acetylcholin
receptor
tmtreat
chick
muscl
cell
may
explain
reduc
receptor
level
sinc
receptor
loss
prevent
part
proteas
inhibitor
leupeptin
rat
basophil
leukemia
cell
grown
presenc
tm
express
fewer
ige
receptor
cell
surfac
judg
ligand
bind
studi
extern
label
procedur
pecoud
et
al
tm
reduc
express
surfac
na
channel
neuroblastoma
cell
waechter
et
al
chicken
muscl
cell
measur
h
saxitoxin
bind
neurotoxinactiv
na
influx
effect
partial
revers
leupeptin
muscl
cell
tm
complet
block
receptor
grow
human
astrocytoma
cell
doss
et
al
inhibitor
influenc
steadyst
level
cell
georg
et
al
presenc
tm
mous
mammari
tumor
viru
mtv
glycoprotein
synthes
virusinfect
hepatoma
cell
accumul
within
cell
proteolyt
process
precursor
polyprotein
occur
transport
mtv
polypeptid
cell
surfac
extracellular
fraction
inhibit
fireston
tm
treatment
also
inhibit
mump
viru
particl
format
herrler
compan
sinc
mump
viru
polypeptid
synthes
presenc
drug
assembl
nucleocapsid
observ
like
tm
block
surfac
express
viral
glycoprotein
nlink
oligosaccharid
k
mous
histocompat
protein
heavi
chain
may
influenc
transport
cellular
distribut
le
doyl
mous
macrophag
k
glycoprotein
exist
two
distinct
form
intracellular
form
high
mannos
type
chain
cell
surfac
form
complex
type
chain
k
glycoprotein
destin
cell
surfac
rapidli
transport
local
synthesi
rer
wherea
intracellular
k
glycoprotein
remain
associ
intracellular
membran
prolong
period
undegrad
form
determin
oligosaccharid
structur
k
glycoprotein
contain
inform
import
intracellular
distribut
macrophag
cultur
treat
tm
condit
inhibit
glycosyl
incomplet
tmtreat
cell
cultur
newli
synthes
nonglycosyl
k
polypeptid
rapidli
transport
cell
surfac
signific
intracellular
pool
contast
inhibitortr
cultur
k
polypeptid
contain
one
two
three
oligosaccharid
side
chain
high
mannos
type
transport
cell
surfac
author
suggest
cell
surfac
express
k
polypeptid
requir
either
process
oligosaccharid
side
chain
high
mannos
form
complex
type
absenc
oligosaccharid
chain
major
human
red
cell
glycoprotein
glycophorin
contain
nlink
glycan
chain
olink
glycan
chain
synthesi
nlink
chain
inhibit
tm
olink
chain
affect
incomplet
glycophorin
lack
nglycosid
oligosaccharid
incorpor
surfac
membran
total
amount
glycophorin
decreas
compar
untreat
cell
gahmberg
et
al
tm
treatment
hepatoma
cell
delay
appear
cell
surfac
barouki
et
al
tm
also
inhibit
transport
cell
surfac
specif
yeast
membran
protein
suggest
glycosyl
necessari
correct
process
intracellular
transport
yeast
membran
protein
novick
schekman
tm
treatment
frog
retina
block
incorpor
opsin
retin
rod
outer
segment
ro
membran
fliesler
basing
effect
tm
may
specif
amphibian
retina
howev
sinc
plantner
et
al
report
inhibit
opsin
glycosyl
tm
bovin
retina
prevent
incorpor
visual
pigment
apoprotein
ro
membran
epitheli
cell
express
cell
surfac
polar
differ
glycoprotein
present
apic
basolater
surfac
recent
review
see
simmon
fuller
roth
et
al
green
et
al
studi
viral
protein
express
madindarbi
canin
kidney
mdck
cell
presenc
tm
saw
mark
effect
polar
similar
result
obtain
mutant
mdck
cell
defect
glycosyl
green
et
al
meiss
et
al
although
nlink
glycosyl
appear
import
role
polar
express
viral
protein
unknown
whether
carbohydr
chain
function
transport
marker
endogen
epitheli
apic
basolater
protein
tm
alter
express
cell
surfac
nonglycosyl
hlaa
hlab
antigen
two
lymphoblastoid
cell
line
owen
et
al
ploegh
et
al
initi
cell
surfac
express
human
complement
receptor
type
human
b
lymphoblastoid
cell
wei
fearon
also
alter
intracellular
rout
turnov
function
asialoglycoprotein
receptor
human
hepatoma
cell
line
breitfeld
et
al
drug
inhibit
specif
step
process
pathway
becom
avail
possibl
studi
role
oligosaccharid
process
intermedi
intracellular
transport
glycoprotein
fig
review
see
lalegeri
et
al
schwarz
datema
elbein
fuhrmann
et
al
nmethyldeoxynojirimycin
castanospermin
inhibit
rer
ii
golgi
endoadmannosidas
drug
prevent
remov
rer
three
glucos
residu
glc
man
glcnac
saunier
et
al
hettkamp
et
al
pan
et
al
palamarczyk
elbein
luba
spiro
bromoconduritol
prevent
trim
glucos
glcman
glcnac
inhibit
aglucosidas
ii
datema
et
al
inhibit
golgi
ib
fuhrmann
et
al
burk
et
al
elbein
et
al
rer
bischoffand
swainsonin
inhibit
golgi
amannosidas
ii
tulsiani
et
al
inhibit
process
glycoprotein
swainsonin
elbein
et
al
elbein
et
al
tulsiani
et
al
result
synthesi
glycoprotein
hybridtyp
oligosaccharid
one
branch
contain
sugar
commonli
found
complex
oligosaccharid
glcnac
gal
neu
ac
mannosecontain
branch
remain
unsubstitut
gross
et
al
tulsiani
touster
arumugham
import
advantag
use
oligosaccharid
process
inhibitor
use
tm
glycoprotein
synthes
treat
cell
lack
nlink
glycan
chain
rather
retain
intermedi
normal
ohgosaccharid
process
pathway
nmethyldeoxynorjirimycin
castanospermin
bromoconduritol
hybrid
oligosaccharid
swainsonin
therefor
unlik
treatment
inhibitor
induc
glycoprotein
aggreg
alter
protein
fold
increas
sensit
proteolysi
simplifi
interpret
studi
use
drug
studi
use
inhibitor
rer
demonstr
trim
glucos
residu
major
nlink
ohgosaccharid
precursor
requir
rapid
matur
specif
secretori
membran
lysosom
enzym
rer
golgi
apparatu
gross
et
al
first
report
treatment
rat
hepatocyt
result
long
delay
secret
r
antitrypsin
cell
accumul
r
antitrypsin
carbohydr
chain
highmannos
type
contain
glucos
largest
speci
glc
man
glcnac
secret
nonglycoprotein
albumin
unaffect
drug
complet
block
ohgosaccharid
process
iantitrypsin
molecul
process
complex
type
one
two
ohgosaccharid
chain
secret
remov
three
glucos
residu
glc
man
precursor
believ
occur
rapidli
transloc
glycoprotein
rer
hubbard
robbin
may
occur
nascent
chain
atkinson
lee
lodish
kong
found
glucos
remov
nlink
oligosaccharid
requir
effici
passag
secretori
glycoprotein
rer
golgi
complex
treatment
inhibit
secret
r
antitrypsin
antichymotrypsin
human
hepatoma
cell
littl
effect
secret
glycoprotein
transferrin
albumin
sinc
remov
r
antitrypsin
secret
normal
inhibitori
effect
revers
cellular
fraction
studi
use
sucros
densiti
gradient
found
drug
treatment
caus
r
antitrypsin
antichymotrypsin
accumul
rer
untreat
cell
iantitrypsin
rapidli
transport
rer
wherea
transferrin
leav
rer
slowli
lodish
kong
postul
rapid
transport
jantitrypsin
antichymotrypsin
rer
golgi
requir
nlink
ohgosaccharid
chain
process
least
man
glcnac
form
ohgosaccharid
form
part
recognit
site
transport
receptor
protein
slow
transport
transferrin
r
antitrypsin
synthes
presenc
would
involv
bind
receptor
rather
bulkphas
fluid
movement
er
golgi
interestingli
human
diseas
r
antitrypsin
defici
z
variant
r
antitrypsin
poorli
secret
liver
accumul
rer
retain
glucos
residu
hybridoma
cell
produc
igd
igm
peyriera
et
al
found
secret
igd
igm
block
experi
use
drug
lemanski
et
al
found
transport
lysosom
enzym
cathepsin
er
golgi
apparatu
depend
remov
glucos
residu
carbohydr
side
chain
effect
surfac
express
vsv
g
protein
influenza
viru
hemagglutinin
human
class
histocompat
antigen
burk
et
al
glucosidas
inhibitor
also
effect
transport
incorrectli
process
erbb
oncogen
glycoprotein
cell
surfac
schmidt
et
al
effect
process
inhibitor
intracellular
migrat
glycoprotein
mous
hepat
viru
studi
repp
et
al
presenc
nmethyldeoxynojirimycin
castanospermin
glycoprotein
synthes
normal
amount
accumul
intracellularli
transport
cell
surfac
greatli
delay
glycoprotein
isol
viru
particl
cell
grown
presenc
nmethyldeoxynojirimycin
carri
predominantli
man
glcnac
oligosaccharid
side
chain
remain
chain
show
trim
one
two
mannos
residu
tm
treatment
also
prevent
surfac
express
glycoprotein
inhibitor
trim
affect
transport
appar
effici
transport
glycoprotein
plasma
membran
requir
remov
glucos
trim
mannos
treatment
sindbi
virusinfect
cell
either
castanospermin
inhibit
proteolyt
cleavag
glycoprotein
polyprotein
precursor
glycoprotein
el
prevent
migrat
precursor
cell
surfac
schlesing
et
al
howev
treatment
sindbu
virusinfect
cell
bromoconduritol
prevent
remov
innermost
glucos
residu
outer
two
glucos
residu
inhibit
proteolyt
cleavag
polyprotein
precursor
fowl
plagu
viru
show
interest
characterist
releas
infecti
viru
inhibit
bromoconduritol
datema
et
al
romero
et
al
unfortun
bromoconduritol
quit
unstabl
halflif
water
min
ph
fact
millimolar
concentr
requir
inhibit
complic
interpret
studi
use
drug
found
treatment
human
hepatoma
cell
inhibit
matur
nlink
glycan
chain
select
group
secretori
glycoprotein
form
resist
digest
endo
h
parent
et
al
also
drug
treatment
inhibit
transport
rer
golgi
subgroup
glycoprotein
includ
r
antitrypsin
ceruloplasmin
macroglobulin
transferrin
afetoprotein
fibronectin
interestingli
tm
treatment
similar
differenti
effect
secret
glycoprotein
sinc
trim
three
glucos
residu
branch
requir
process
nlink
chain
endo
hresist
form
major
nlink
glycan
process
pathway
harpaz
schachter
find
treatment
inhibit
matur
nlink
glycan
secretori
glycoprotein
unexpect
one
possibl
explan
result
glycan
chain
secretori
glycoprotein
process
resist
drug
altern
may
anoth
pathway
process
nlink
glycan
side
chain
secretori
glycoprotein
endo
hresist
form
involv
glycosyl
intermedi
explan
consist
previou
report
literatur
reitman
et
al
examin
glycopeptid
produc
mous
lymphoma
cell
line
sever
defici
less
parent
rer
aglucosidas
ii
major
oligosaccharid
produc
mutant
character
glc
man
glcnac
man
glcnac
howev
mutant
still
contain
complex
chain
parent
line
author
suggest
mutant
may
still
enough
aglucosidas
ii
allow
process
complex
chain
may
altern
pathway
parodi
et
al
shown
glucosefre
oligosaccharid
transfer
nglycosyl
protein
protozoa
trypanosoma
cruzi
romero
herscov
demonstr
transfer
glucosefre
oligosaccharid
lipid
protein
mammalian
cell
line
krag
describ
cho
cell
mutant
select
increas
resist
concanavalin
defect
glucosyl
lipidlink
oligosaccharid
interestingli
incorpor
mannos
glycoprotein
occur
near
normal
rate
mutant
cell
also
synthes
high
level
complextyp
oligosaccharid
krag
person
commun
similarli
studi
use
sever
differ
glucosidas
inhibitor
datema
et
al
pan
et
al
gross
et
al
romero
et
al
inhibit
synthesi
complextyp
glycan
chain
complet
even
high
concentr
inhibitor
suggest
either
process
activ
resist
inhibitor
altern
pathway
luba
spiro
describ
novel
enzym
present
golgi
membran
capabl
convert
glciman
glcnac
unit
man
glcnac
releas
endomannosidas
fulli
activ
presenc
author
point
altern
pathway
remov
glucos
mannos
disaccharid
rather
sequenti
releas
monosaccharid
aglucosidas
l
could
provid
explan
incomplet
block
oligosaccharid
process
observ
cell
inhibit
defici
altern
pathway
may
also
explain
treatment
hepatoma
cell
differenti
effect
glycan
matur
intracellular
transport
specif
secretori
glycoprotein
parent
et
al
least
four
distinct
exoamannosidas
respons
trim
six
mannos
residu
convers
glc
man
glcnac
oligosaccharid
complex
form
major
process
pathway
nlink
glycan
fig
inhibitor
three
trim
mannosidas
known
yet
inhibitor
report
amannosidas
activ
local
rer
bischoff
kornfeld
inhibitor
trim
unlik
aglycosidas
appear
dramat
effect
transport
secretori
membran
glycoprotein
inhibit
golgi
mannosidas
ib
block
convers
highmannos
oligosaccharid
complextyp
oligosaccharid
prevent
secret
either
igd
igm
fuhrmann
et
al
contrast
block
secret
igd
gross
et
al
found
highmannosetyp
r
antitrypsin
aacid
glycoprotein
secret
hepatocyt
rate
normal
glycoprotein
use
anoth
inhibitor
amannopyranosylmethylpnitrophenyltriazen
docherti
et
al
found
drug
treatment
alter
secret
r
acid
glycoprotein
although
secret
form
contain
man
chain
rather
usual
complextyp
chain
also
without
effect
surfac
express
sever
membran
glycoprotein
test
vsv
g
protein
influenza
viru
hemagglutinin
human
class
histocompat
antigen
burk
et
al
elbein
et
al
inhibit
golgi
l
er
use
determin
role
er
process
nlink
oligosaccharid
glycoprotein
intact
cell
bischoff
et
al
analysi
total
h
mannos
label
nlink
oligosaccharid
synthes
control
rat
hepatocyt
indic
onethird
oligosaccharid
secretori
glycoprotein
onehalf
oligosaccharid
cellular
glycoprotein
rat
hepatocyt
cultur
process
er
amannosidas
result
similar
studi
use
cell
line
indic
er
respons
convers
man
glcnac
oligosaccharid
man
glcnac
unit
resid
er
glycoprotein
reductas
bischoff
et
al
find
specif
glycoprotein
substrat
er
addit
evid
multipl
oligosaccharid
process
pathway
cell
swainsonin
inhibitor
golgi
amannosidas
ii
k
found
swainsonin
treatment
human
hepatoma
cell
acceler
secret
number
glycoprotein
transferrin
ceruloplasmin
niacroglobulin
r
antitrypsin
decreas
lag
period
secret
min
rel
untreat
cultur
sinc
convers
highmannos
precursor
r
antitrypsin
hybrid
form
swainsoninetr
cell
occur
rapidli
min
convers
complex
form
control
cell
result
suggest
swainsoninemodifi
glycoprotein
hepatoma
cell
travers
golgi
rapidli
normal
counterpart
magnitud
effect
rate
protein
secret
small
howev
studi
report
swainsonin
treatment
littl
effect
secret
number
protein
includ
fibronectin
skin
fibroblast
arumugham
iantitrypsin
rat
hepatocyt
gross
et
al
aminopeptidas
n
organcultur
intestin
mucos
explant
danielsen
et
al
five
glycoprotein
human
hepatoma
cell
lodish
kong
surfactantassoci
glycoprotein
lung
epitheli
cell
whitsett
et
al
treatment
thyroid
cell
swainsonin
increas
halftim
maxim
secret
thyroglobulin
min
frank
et
al
addit
swainsonin
treatment
littl
effect
intracellular
rout
turnov
function
asialoglycoprotein
receptor
human
hepatoma
cell
breitfeld
et
al
soderquist
carpent
demonstr
drug
treatment
cell
result
product
incomplet
process
egf
receptor
still
abl
function
normal
duronio
et
al
found
swainsonin
treatment
significantli
affect
movement
insulin
insulinlik
growth
factor
receptor
cell
proteolyt
process
hormon
bind
hormonestimul
autophosphoryl
number
affin
receptor
swainsoninetr
cell
normal
georg
et
al
influenza
particl
isol
swainsoninetr
infect
cell
infect
hemagglutin
titer
viru
particl
control
cell
elbein
et
al
receptormedi
traffick
lysosom
acid
hydrolas
oligosaccharid
contain
phosphoryl
mannos
best
understood
pathway
protein
translat
rer
segreg
deliv
ultim
destin
review
see
sli
von
figura
hasilik
robbin
chapter
volum
current
thought
newli
synthes
acid
hydrolas
bear
transport
marker
bind
specif
receptor
locat
golgi
membran
transport
golgi
cisterna
receptormedi
process
similar
occur
cell
surfac
receptorligand
complex
deliv
vesicl
lysosom
low
ph
caus
dissoci
receptor
two
receptor
bind
specif
identifi
first
isol
kda
integr
membran
protein
found
mani
differ
cell
type
sahagian
et
al
recent
second
receptor
isol
murin
macrophag
bovin
liver
differ
kda
receptor
subunit
molecular
weight
kda
oligosaccharidebind
specif
requir
dival
cation
bind
hoflack
kornfeld
b
new
receptor
name
cationdepend
receptor
cd
receptor
distinguish
kda
cationindepend
receptor
ci
receptor
preliminari
experi
hoflack
kornfeld
identifi
cd
receptor
number
cell
type
includ
contain
ci
receptor
suggest
two
receptor
may
involv
target
acid
hydrolas
differ
popul
lysosom
cell
addit
two
receptor
number
carbohydratebind
protein
lectin
identifi
vertebr
cell
tabl
although
physiolog
function
gener
unclear
may
role
intracellular
transport
target
glycoprotein
review
see
ashwel
harford
barond
barond
kobil
vertebr
lectin
classifi
roughli
two
group
first
compris
integr
membran
protein
gener
high
molecular
weight
solubil
deterg
lectin
tabl
second
compris
group
solubl
peripher
membran
protein
low
molecular
weight
often
development
regul
lectin
tabl
mani
carbohydratebind
membran
receptor
known
bind
intern
glycoprotein
often
assum
function
cell
surfac
howev
one
import
lesson
come
work
receptor
lysosom
local
identif
effici
cell
surfac
receptormedi
glycoprotein
uptak
system
necessarili
mean
primari
vivo
function
receptor
associ
plasma
membran
identif
ci
receptor
result
earlier
studi
found
fibroblast
patient
variou
inherit
lyosom
storag
diseas
could
take
lysosom
enzym
secret
normal
fibroblast
process
specif
satur
neufeld
et
al
earli
model
deliveri
acid
hydrolas
lysosom
suggest
neufeld
et
al
emphas
role
cell
surfac
receptor
activ
postul
main
rout
incorpor
enzym
lysosom
requir
prior
secret
recaptur
cell
subsequ
studi
support
model
von
figura
weber
sli
stahl
vladutiu
ratazzi
demonstr
small
fraction
receptor
activ
local
cell
surfac
direct
attent
physiolog
role
intracellular
receptor
gener
accept
major
pathway
transport
hydrolas
lysosom
mediat
receptor
golgi
membran
like
ci
receptor
sever
carbohydratebind
protein
also
concentr
intracellular
membran
pricer
ashwel
demonstr
bind
h
asialoorosomucoid
golgi
lysosom
membran
isol
rat
liver
observ
confirm
studi
solubil
hepatocyt
steer
ashwel
rat
hepatocyt
found
contain
total
asialoglycoprotein
receptor
resid
plasma
membran
similar
result
provid
weigel
oka
use
hepatocyt
permeabil
digitonin
man
glcnacbind
activ
alveolar
macrophag
could
inhibit
mild
trypsin
suggest
receptor
may
insid
cell
inaccess
trypsin
stahl
et
al
result
subsequ
confirm
direct
bind
assay
cell
made
permeabl
presenc
saponin
wileman
et
al
human
fibroblast
contain
larg
intracellular
pool
bind
site
specif
pool
contain
total
receptor
found
cell
fisher
et
al
presenc
permeabil
agent
saponin
digitonin
macrophag
receptor
show
distribut
surfac
insid
shepherd
et
al
receptor
distribut
within
cell
also
studi
electron
microscopi
antibodi
bound
asialoglycoprotein
receptor
visual
frozen
section
incub
colloid
gold
absorb
protein
quantit
analysi
gold
bead
distribut
section
hepatocyt
show
hoflack
kornfeld
hoflack
kornfeld
ashwel
harford
schwartz
kawasaki
ashwel
drickam
maynard
baenzig
stahl
et
al
haltiwang
et
al
lennartz
et
al
lehrman
et
al
b
c
haltiwang
et
al
maynard
baenzig
mori
et
al
brownel
et
al
mori
et
al
colley
baenzig
b
kolbbachofen
et
al
roo
et
al
schlepperschof
et
al
jakoi
et
al
marchas
et
al
barond
barond
beyer
et
al
harrison
chesterton
ceri
et
al
receptor
confin
plasma
membran
rest
found
near
golgi
smooth
endoplasm
reticulum
endosom
membran
guez
et
al
guez
et
al
asialoglycoprotein
receptor
mammalian
hepatocyt
extens
studi
model
system
receptormedi
endocytosi
review
see
harford
ashwel
schwartz
weigel
vivo
function
receptor
howev
uncertain
numer
investig
shown
mani
system
desialyl
glycoprotein
inject
mammal
rapidli
remov
serum
receptor
liver
howev
four
laboratori
shown
normal
circumst
serum
glycoprotein
desialyl
vivo
clear
circul
receptor
wong
et
al
clarenburg
kuranda
aronson
lefort
et
al
vertebr
lectin
bind
specif
sugar
commonli
found
membran
secretori
glycoprotein
sever
known
bind
specif
sugar
occur
nonreduc
termini
oligosaccharid
chain
sarkar
et
al
brile
et
al
kawasaki
ashwel
exampl
liver
cell
contain
surfac
receptor
bind
glycan
chain
contain
termin
fucos
linkag
glycan
chain
contain
termin
fucos
linkag
appear
recogn
lectin
prieel
et
al
asialoglycoprotein
receptor
mammalian
liver
bind
glctermin
oligosaccharid
addit
galand
galnactermin
oligosaccharid
stowel
lee
baenzig
maynard
purifi
human
hepat
asialoglycoprotein
receptor
much
higher
affin
bind
complex
oligosaccharid
bear
three
termin
gal
residu
two
residu
baenzig
maynard
triantennari
complex
oligosaccharid
three
termin
gal
residu
rapidli
endocytos
hepatocyt
complex
oligosaccharid
one
two
termin
gal
residu
endocytos
although
bound
hepatocyt
baenzig
fiet
maynard
baenzig
studi
specif
man
glcnac
receptor
bind
nlink
glycan
chain
found
minimum
structur
requir
bind
endocytosi
rat
liver
reticuloendotheli
cell
six
residu
oligosaccharid
attach
addit
sugar
residu
hexasaccharid
prevent
bind
endocytosi
liver
reticuloendotheli
cell
lectin
must
extend
bind
site
accommod
sever
sugar
highli
restrict
bind
specif
manglcnacspecif
lectin
isol
rabbit
rat
liver
affin
chromatographi
mannansepharos
kawasaki
et
al
mizuno
et
al
townsend
stahl
detail
character
lectin
carbohydr
specif
maynard
baenzig
indic
structur
requir
recognit
nlink
glycan
includ
primarili
core
region
oligosaccharid
chain
plu
least
peptid
lectin
mostli
associ
rough
microsom
fraction
liver
mori
et
al
either
solubl
peripher
membran
protein
rather
integr
membran
protein
sinc
extract
without
deterg
maynard
baenzig
mori
et
al
mori
et
al
found
gradient
lectin
occup
endogen
glycoprotein
rer
golgi
lectin
bind
site
rough
microsom
onethird
bind
site
smooth
microsom
golgi
membran
occupi
specif
bound
ie
mannandisplac
glycoprotein
respect
manglcnac
lectin
resembl
ci
receptor
also
found
associ
endogen
ligand
fisher
et
al
manglcnac
lectin
also
found
plasma
number
mammal
kozutsumi
et
al
brownel
et
al
report
lectin
secret
hepatocyt
hepatoma
cell
howev
kinet
secret
unusu
slow
lectin
secret
hr
although
vivo
function
liver
manglcnac
lectin
current
unclear
bind
specif
local
rer
associ
endogen
ligand
led
suggest
lectin
may
serv
carrier
protein
transport
biosynthet
intermedi
glycoprotein
highmannosetyp
oligosaccharid
rer
gogi
apparatu
mori
et
al
kawasaki
et
al
altern
lectin
may
serv
anchor
glycoprotein
within
cistern
space
er
prevent
move
golgi
apparatu
describ
le
doyl
presenc
highmannosetyp
oligosaccharid
chain
microsom
enzym
support
latter
hypothesi
mizuochi
et
al
liscum
et
al
solubl
lectin
bind
specif
lactos
implic
secret
mucin
chicken
intestin
mucosa
chicken
lactoselectin
minor
compon
chicken
lactoselectin
ii
local
secretori
vesicl
goblet
cell
intestin
mucosa
beyer
et
al
beyer
barond
purifi
chicken
intestin
mucin
also
concentr
vesicl
interact
lectin
sinc
potent
inhibitor
specif
hemagglutin
activ
result
suggest
lectin
somehow
involv
organ
andor
secret
mucin
goblet
cell
intestin
lumen
marchas
et
al
identifi
distinct
subclass
peripher
membran
glycoprotein
whose
nlink
glycan
chain
unlik
lysosom
contain
phosphodiesterlink
glucos
lectin
ligatin
isol
bind
site
phosphooligosaccharid
seem
util
bind
site
secur
phosphoglucosecontain
glycoprotein
extern
surfac
cell
ligatin
first
identifi
filament
basepl
morpholog
distinct
array
molecul
suckl
rat
ileum
jakoi
et
al
sinc
found
bind
hydrolas
rat
macrophag
brain
gaston
et
al
addit
found
embryon
chicken
neural
retina
jakoi
marchas
inhibit
intercellular
adhes
dissoci
retin
cell
marchas
et
al
thu
implic
intercellular
recognit
although
ident
ligatin
prepar
sourc
close
relat
share
follow
properti
solubil
membran
high
ca
concentr
depolymer
ethylenebi
oxyethylenenitrilo
tetraacet
acid
form
filament
nm
diamet
presenc
ca
appar
monomer
molecular
weight
possess
amino
acid
composit
character
rel
high
level
acid
residu
low
level
hydrophob
residu
addit
affin
studi
bind
protein
cosolubil
releas
protein
treatment
specif
phosphoryl
sugar
synthet
origin
phosphat
present
ligatinassoci
oligosaccharid
studi
hiller
et
al
similar
result
found
reitman
kornfeld
hasilik
et
al
studi
lysosom
enzym
presenc
phosphat
ligatinassoci
oligosaccharid
seem
aris
transfer
sugar
phosphoglycosyltransferas
termin
mannos
residu
highmannos
nlink
oligosaccharid
reaction
udpglc
glycoprotein
glcptransferas
retin
system
udpglc
oligosaccharid
oligosaccharidepglc
ump
unlik
synthesi
lysosom
transport
marker
phosphodiest
linkag
describ
ligatinassoci
retin
cell
surfac
protein
seem
undergo
cleavag
vivo
expos
sinc
phosphodiesterlink
glucos
present
cell
surfac
prepar
appar
requir
bind
ligatin
locat
ligatin
associ
phosphoglycoprotein
cell
surfac
led
suggest
ligatin
may
function
intracellular
local
phosphodiesterlink
glucos
may
tag
target
specif
glycoprotein
surfac
membran
much
way
target
acid
hydrolas
lysosom
marchas
et
al
marchas
et
al
marchas
et
al
newli
synthes
glycoprotien
destin
cell
surfac
may
share
common
featur
peptid
structur
would
result
recognit
glcptransferas
phosphodiesterlink
glucos
would
recogn
receptor
distinct
receptor
util
local
lysosom
hydrolas
receptor
could
ligatin
anoth
protein
similar
bind
specif
recognit
would
ultim
lead
segreg
protein
vesicl
transport
cell
surfac
cell
surfac
protien
could
establish
stabl
presenc
bind
cell
surfac
basepl
ligatin
addit
studi
need
howev
confirm
interest
model
stepwis
transport
newli
synthes
secretori
membran
glycoprotien
subcompart
rer
golgi
apparatu
cell
surfac
highli
regul
presum
signal
sort
mechan
essenti
everi
step
proper
traffic
regul
evid
carbohydr
group
import
function
role
intracellular
transport
andor
sort
specif
secretori
membran
glycoprotein
increas
substanti
last
year
eleg
studi
laboratori
john
rose
use
sitedirect
mutagenesi
techniqu
clearli
demonstr
nlink
glycan
chain
promot
effici
transport
specif
membran
protein
cell
surfac
close
associ
glycosyl
defect
alter
express
antigen
receptor
ldl
receptor
emphas
import
carbohydr
chain
express
function
cell
surfac
glycoprotein
mani
glycoprotein
fail
secret
express
cell
surfac
normal
glycosyl
inhibit
tm
addit
studi
mostli
use
demonstr
trim
glucos
residu
nlink
glycan
chain
specif
secretori
lysosom
membran
protein
requir
effici
transport
glycoprotein
rer
golgi
although
studi
demonstr
carbohydr
group
import
traffic
mani
secretori
membran
glycoprotein
precis
role
carbohydr
intracellular
transport
unclear
analog
pathway
transport
acid
hydrolas
lysosom
tempt
postul
specif
carbohydratebind
receptor
mediat
intracellular
transport
specif
nonlysosom
glycoprotein
clearli
establish
yet
howev
effort
identifi
iolat
carbohydratebind
transport
receptor
distinct
form
receptor
clearli
indic
futur
studi
area
also
import
determin
complet
structur
oligosaccharid
chain
attach
glycoprotein
investig
consider
evid
altern
pathway
process
nlink
glycan
detail
structur
inform
probabl
requir
make
signific
progress
understand
presum
complex
role
carbohydr
glycoprotein
traffic
